Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population
Genomic analysis, performed on tumoral tissue DNA and on circulating tumor DNA (ctDNA) from blood, is the cornerstone of precision cancer medicine. Herein, we characterized the clinical prognostic implications of the concordance of alterations in major cancer genes between tissue‐ and blood‐derived...
Main Authors: | Shai Rosenberg, Gil Ben Cohen, Shumei Kato, Ryosuke Okamura, Scott M. Lippman, Razelle Kurzrock |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13383 |
Similar Items
-
Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
by: Ruchi Agashe, et al.
Published: (2020-08-01) -
Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer
by: E. M. Polyanskaya, et al.
Published: (2022-04-01) -
Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes
by: Bryce Demoret, et al.
Published: (2019-11-01) -
Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
by: Jacob J. Adashek, et al.
Published: (2021-07-01) -
Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology
by: Masahiko Aoki, et al.
Published: (2020-05-01)